摘要

Objectives: Weight loss is the biggest stigma all around the globe and drug that gained attention was the GLP 1 agonist known as ozempic which has brought both positive and negative impact in Life. In aesthetic world ozempic fascies have referred to hollowness in cheeks extra skin laxity, atrophy of mid face and shift and deflating of fats hence different compartment acts differently. Introduction: The advent of GLP-1 agonists like Ozempic has revolutionized weight management but has also introduced aesthetic challenges. As individuals lose weight, changes in facial structure, often referred to as "Ozempic fascies," can lead to a hollow appearance and skin laxity. These changes can negatively impact self-esteem and overall quality of life, prompting the need for effective aesthetic interventions. This study explores the use of specific dermal fillers to counteract these effects, aiming to restore facial volume and improve overall appearance while aligning with patient desires for natural Materials / method: By considering the fact of adipose tissue different sizes with different septal network and different treatment modalities are selected to reuse such changes. In this split cohort study I utilized two types of dermal fillers. Polycaprolactone and Hyaluronic acid. Both fillers targeted superficial fat compartments replacement. To re-contour the deep nasolabial fold and re-shift the fats. I employed suspension sutures composing PCL-PLA micro, Nano and Sub-micro HA Capsules. Longevity is approximately 2 years assuming stable weight and moderate activities. Results: Results show enhanced fascial rejuvenation with sustained effects on skin rejuvenation. This gives natural and subtle results aligning perfectly with the ultimate goal for our aesthetic patients. Conclusion: This study demonstrates concurrent improvement in fat repositioning and filling.